ロード中...
Neoadjuvant Endocrine Therapy in Breast Cancer
Women who suffer from large or locally advanced malignant breast tumors are now commonly treated with preoperative (‘neoadjuvant’) systemic therapy to improve surgical outcomes and to raise the chances for breast-conserving therapy (BCT). Until recently, chemotherapy was the treatment of choice, and...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
S. Karger GmbH
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2931101/ https://ncbi.nlm.nih.gov/pubmed/20824024 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000152005 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|